{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10516835", "DateCompleted": {"Year": "1999", "Month": "11", "Day": "19"}, "DateRevised": {"Year": "2016", "Month": "10", "Day": "21"}, "Article": {"ArticleDate": [], "Language": ["ger"], "ELocationID": [], "Journal": {"ISSN": "0933-4548", "JournalIssue": {"Volume": "51", "Issue": "3", "PubDate": {"Year": "1999", "Month": "Sep", "Day": "01"}}, "Title": "Versicherungsmedizin", "ISOAbbreviation": "Versicherungsmedizin"}, "ArticleTitle": "[Herbal drugs of foreign cultures and medical systems exemplified by Indian incense. Considerations regarding social and insurance medicine expert assessment].", "Pagination": {"StartPage": "122", "EndPage": "127", "MedlinePgn": "122-7"}, "Abstract": {"AbstractText": ["Increase preparations are being used with increasing frequency in Western medicine. In experimental investigations, an anti-inflammatory effect has been shown. Clinical observations relate to increase applications in rheumatoid arthritis, malignant brain tumors, inflammatory bowel diseases and asthma bronchiale. A relevant clinical effect of increase preparations has not been ascertained. In Germany, the registration of increase preparation H 15 as a drug has been withheld by the federal drug registration office (former \"Bundesgesundheitsamt\"). Health funds may reimburse costs for increase preparations in exceptional cases only."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "MDK in Hessen, Universit\u00e4tsspital Z\u00fcrich."}], "Identifier": [], "LastName": "Kreck", "ForeName": "C", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Saller", "ForeName": "R", "Initials": "R"}], "PublicationTypeList": ["English Abstract", "Journal Article"], "VernacularTitle": "Phytopharmaka fremder Kulturkreise beziehungsweise Medizinsysteme am Beispiel des indischen Weihrauchs. Uberlegungen zur sozial- und versicherungsmedizinischen Begutachtung."}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Versicherungsmedizin", "NlmUniqueID": "8803623"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["legislation & jurisprudence"], "DescriptorName": "Drug Approval"}, {"QualifierName": ["legislation & jurisprudence"], "DescriptorName": "Expert Testimony"}, {"QualifierName": [], "DescriptorName": "Germany"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "India"}, {"QualifierName": [], "DescriptorName": "Medicine, Traditional"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1999", "Month": "10", "Day": "12"}, {"Year": "1999", "Month": "10", "Day": "12", "Hour": "0", "Minute": "1"}, {"Year": "1999", "Month": "10", "Day": "12", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10516835"]}}], "PubmedBookArticle": []}